BOSTON--(BUSINESS WIRE)--Pison Technology, the pioneers behind AI-powered neural biosensors for health, wellness and cognitive performance, today announced the appointment of William B. Gormley, MD, MPH as chief medical officer (CMO), Cris Cairo as chief product officer (CPO), and John Joseph as chief revenue officer (CRO). These key leadership appointments are vital developments as Pison prepares to launch groundbreaking cognitive performance products for competitive athletes and professional knowledge workers, while it continues to refine its groundbreaking gesture capabilities for spatial computing.
Dr. Gormley is the director of neurosurgical innovation at Brigham and Women’s Hospital, co-director of Cushing Neurological Outcomes Center and an associate professor at Harvard Medical School. Throughout his career, Dr. Gormley has striven to drive innovation and change in the healthcare space through data, analytics, research, the development of new medical devices and the accessibility of digital health technologies. In this new role, Dr. Gormley will lead Pison’s research, engineering and product teams as they build solutions that help detect, diagnose and treat significant diseases.
As CPO, Cairo will prioritize technical feasibility and commercial viability as he develops product strategies, launches initiatives and spearheads Pison’s partnership with global suppliers and distributors. He will leverage his vast experience at Nokia, Ericsson, and Acorn to drive digital health, wellness and fitness innovation and future product development across diversified markets from competitive athletes to the healthcare industry.
Joseph has 25 years of product and marketing experience, successfully bringing category-creating technology products to market across a variety of areas including SaaS, AI, wearable sensors, IoT and healthcare. In senior leadership roles at Net Health, Endeca and InterSystems, Joseph expanded product and digital marketing capabilities, drove growth and launched numerous initiatives, including Net Health’s first AI-based analytics product. As CRO, Joseph will lead Pison’s go-to-market efforts, the development and execution of the sales and marketing strategy, and the launch and growth of the company’s revolutionary consumer and healthcare products.
“We are honored to have Bill, Cris and John join Pison, ” said John Croteau, CEO of Pison Technology. “They bring many decades of proven experience and track records of success for deterministic execution of our new company strategy. We’re poised to transform users’ ability to manage their mental preparation and cognitive performance at work and play—from competitive athletes and doctors to truck drivers. Under our expanding team’s leadership, we aspire to reinvent healthcare and enable people to live long and fruitful lives. We couldn’t be more excited about the new products, services, and partnerships that we’re readying to launch after the New Year.”
To learn more about Pison Technology, visit www.pison.com.
About Pison Technology
Pison is advancing the frontier of human potential with the world’s first AI-infused, neural biosensing platform. Patented, non-invasive electroneurography (ENG) algorithms create life-changing applications in cognitive performance, disease diagnostics and management, and ongoing care. Pison began in 2016 with funding from the Massachusetts Institute of Technology, National Science Foundation and the ALS Association to help patients with neurodegenerative disorders better navigate the world made smaller by their diseases. By harnessing the power of the mind in real-time, wearers gain access to better health and higher achievement in every domain while reaching peak mental and physical performance on the playing field, in the office, and behind the wheel of a car. Learn more at https://pisontechnology.com/